The global Hospital Infection Therapeutics market was valued at US$ 2569.7 million in 2023 and is projected to reach US$ 3083.5 million by 2030, at a CAGR of 2.6% during the forecast period.
This research report provides a comprehensive analysis of the Hospital Infection Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hospital Infection Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hospital Infection Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Hospital Infection Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hospital Infection Therapeutics market presents opportunities for various stakeholders, including Hospital Acquired Pneumonia, Surgical Site Infections. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hospital Infection Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The research report on the Hospital Infection Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hospital Infection Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Hospital Infection Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antibacterial Drugs, Antiviral Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hospital Infection Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hospital Infection Therapeutics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hospital Infection Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Hospital Infection Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Hospital Infection Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hospital Infection Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hospital Infection Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hospital Infection Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Hospital Infection Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Antibacterial Drugs
- Antiviral Drugs
- Antifungal Drugs
Market segment by Application
- Hospital Acquired Pneumonia
- Surgical Site Infections
- Urinary Tract Infection
- Gastrointestinal Disorders
- Bloodstream Infections
- Others
Global Hospital Infection Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Bayer
- Johnson & Johnson Services
- Actavis
- Sanofi
- Bristol Myers Squibb Company
- AstraZeneca
- Pfizer
- Merck
- GlaxoSmithkline
- Cubist Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital Infection Therapeutics, market overview.
Chapter 2: Global Hospital Infection Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Hospital Infection Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital Infection Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital Infection Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Infection Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Infection Therapeutics Overall Market Size
2.1 Global Hospital Infection Therapeutics Market Size: 2023 VS 2030
2.2 Global Hospital Infection Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Infection Therapeutics Players in Global Market
3.2 Top Global Hospital Infection Therapeutics Companies Ranked by Revenue
3.3 Global Hospital Infection Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hospital Infection Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Hospital Infection Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Infection Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Hospital Infection Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Infection Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital Infection Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Antibacterial Drugs
4.1.3 Antiviral Drugs
4.1.4 Antifungal Drugs
4.2 By Type - Global Hospital Infection Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Hospital Infection Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Hospital Infection Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Infection Therapeutics Market Size, 2023 & 2030
5.1.2 Hospital Acquired Pneumonia
5.1.3 Surgical Site Infections
5.1.4 Urinary Tract Infection
5.1.5 Gastrointestinal Disorders
5.1.6 Bloodstream Infections
5.1.7 Others
5.2 By Application - Global Hospital Infection Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Hospital Infection Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Hospital Infection Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Hospital Infection Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Hospital Infection Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Hospital Infection Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Hospital Infection Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Hospital Infection Therapeutics Revenue, 2019-2030
6.3.2 US Hospital Infection Therapeutics Market Size, 2019-2030
6.3.3 Canada Hospital Infection Therapeutics Market Size, 2019-2030
6.3.4 Mexico Hospital Infection Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Hospital Infection Therapeutics Revenue, 2019-2030
6.4.2 Germany Hospital Infection Therapeutics Market Size, 2019-2030
6.4.3 France Hospital Infection Therapeutics Market Size, 2019-2030
6.4.4 U.K. Hospital Infection Therapeutics Market Size, 2019-2030
6.4.5 Italy Hospital Infection Therapeutics Market Size, 2019-2030
6.4.6 Russia Hospital Infection Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Hospital Infection Therapeutics Market Size, 2019-2030
6.4.8 Benelux Hospital Infection Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Hospital Infection Therapeutics Revenue, 2019-2030
6.5.2 China Hospital Infection Therapeutics Market Size, 2019-2030
6.5.3 Japan Hospital Infection Therapeutics Market Size, 2019-2030
6.5.4 South Korea Hospital Infection Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Hospital Infection Therapeutics Market Size, 2019-2030
6.5.6 India Hospital Infection Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Hospital Infection Therapeutics Revenue, 2019-2030
6.6.2 Brazil Hospital Infection Therapeutics Market Size, 2019-2030
6.6.3 Argentina Hospital Infection Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Infection Therapeutics Revenue, 2019-2030
6.7.2 Turkey Hospital Infection Therapeutics Market Size, 2019-2030
6.7.3 Israel Hospital Infection Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Hospital Infection Therapeutics Market Size, 2019-2030
6.7.5 UAE Hospital Infection Therapeutics Market Size, 2019-2030
7 Hospital Infection Therapeutics Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Hospital Infection Therapeutics Major Product Offerings
7.1.4 Bayer Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Bayer Key News & Latest Developments
7.2 Johnson & Johnson Services
7.2.1 Johnson & Johnson Services Company Summary
7.2.2 Johnson & Johnson Services Business Overview
7.2.3 Johnson & Johnson Services Hospital Infection Therapeutics Major Product Offerings
7.2.4 Johnson & Johnson Services Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Johnson & Johnson Services Key News & Latest Developments
7.3 Actavis
7.3.1 Actavis Company Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Hospital Infection Therapeutics Major Product Offerings
7.3.4 Actavis Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Actavis Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Hospital Infection Therapeutics Major Product Offerings
7.4.4 Sanofi Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Sanofi Key News & Latest Developments
7.5 Bristol Myers Squibb Company
7.5.1 Bristol Myers Squibb Company Company Summary
7.5.2 Bristol Myers Squibb Company Business Overview
7.5.3 Bristol Myers Squibb Company Hospital Infection Therapeutics Major Product Offerings
7.5.4 Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Bristol Myers Squibb Company Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Hospital Infection Therapeutics Major Product Offerings
7.6.4 AstraZeneca Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Hospital Infection Therapeutics Major Product Offerings
7.7.4 Pfizer Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Hospital Infection Therapeutics Major Product Offerings
7.8.4 Merck Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Merck Key News & Latest Developments
7.9 GlaxoSmithkline
7.9.1 GlaxoSmithkline Company Summary
7.9.2 GlaxoSmithkline Business Overview
7.9.3 GlaxoSmithkline Hospital Infection Therapeutics Major Product Offerings
7.9.4 GlaxoSmithkline Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.9.5 GlaxoSmithkline Key News & Latest Developments
7.10 Cubist Pharmaceuticals
7.10.1 Cubist Pharmaceuticals Company Summary
7.10.2 Cubist Pharmaceuticals Business Overview
7.10.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Major Product Offerings
7.10.4 Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Cubist Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital Infection Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hospital Infection Therapeutics Market Drivers in Global Market
Table 3. Hospital Infection Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hospital Infection Therapeutics in Global Market
Table 5. Top Hospital Infection Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Hospital Infection Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Hospital Infection Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Hospital Infection Therapeutics Product Type
Table 9. List of Global Tier 1 Hospital Infection Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Infection Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Hospital Infection Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Hospital Infection Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Hospital Infection Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Hospital Infection Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Hospital Infection Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Hospital Infection Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Hospital Infection Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Hospital Infection Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. Bayer Company Summary
Table 31. Bayer Hospital Infection Therapeutics Product Offerings
Table 32. Bayer Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. Bayer Key News & Latest Developments
Table 34. Johnson & Johnson Services Company Summary
Table 35. Johnson & Johnson Services Hospital Infection Therapeutics Product Offerings
Table 36. Johnson & Johnson Services Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. Johnson & Johnson Services Key News & Latest Developments
Table 38. Actavis Company Summary
Table 39. Actavis Hospital Infection Therapeutics Product Offerings
Table 40. Actavis Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Actavis Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Hospital Infection Therapeutics Product Offerings
Table 44. Sanofi Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. Sanofi Key News & Latest Developments
Table 46. Bristol Myers Squibb Company Company Summary
Table 47. Bristol Myers Squibb Company Hospital Infection Therapeutics Product Offerings
Table 48. Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Bristol Myers Squibb Company Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Hospital Infection Therapeutics Product Offerings
Table 52. AstraZeneca Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Hospital Infection Therapeutics Product Offerings
Table 56. Pfizer Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Hospital Infection Therapeutics Product Offerings
Table 60. Merck Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. GlaxoSmithkline Company Summary
Table 63. GlaxoSmithkline Hospital Infection Therapeutics Product Offerings
Table 64. GlaxoSmithkline Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. GlaxoSmithkline Key News & Latest Developments
Table 66. Cubist Pharmaceuticals Company Summary
Table 67. Cubist Pharmaceuticals Hospital Infection Therapeutics Product Offerings
Table 68. Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. Cubist Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Hospital Infection Therapeutics Segment by Type in 2023
Figure 2. Hospital Infection Therapeutics Segment by Application in 2023
Figure 3. Global Hospital Infection Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hospital Infection Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hospital Infection Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Infection Therapeutics Revenue in 2023
Figure 8. By Type - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Hospital Infection Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 16. US Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 28. China Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Hospital Infection Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Hospital Infection Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. Bayer Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Johnson & Johnson Services Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Actavis Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Sanofi Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bristol Myers Squibb Company Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. AstraZeneca Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Merck Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. GlaxoSmithkline Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Cubist Pharmaceuticals Hospital Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
